SEC Form 4 · accession 0001179110-17-014102
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Wheeler
Officer — President & CEO · Director
Period of report
Nov 10, 2017
Accepted (ET)
Nov 14, 2017 · 2:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 10, 2017 | S | 1,852 | $13.25 | D | 258,602 | D | |
| Common Stock | holding | — | — | — | 282,638 | I | Craig Wheeler Revocable Trust | |
| Common Stock | holding | — | — | — | 45,980 | I | Craig A Wheeler 2016 Annuity Trust | |
| Common Stock | holding | — | — | — | 49,967 | I | Craig A Wheeler 2014 Annuity Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2016.
- F2This transaction was executed in multiple trades at prices ranging from $13.15 to $13.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.